TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma
Authors (first, second and last of 18)
The "Journal of Cancer Research and Clinical Oncology" publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal, which is chiefly devoted to Original papers, also includes Reviews as well as Editorials and Guest editorials on current, controversial topics. The section Letters to the editors provides a forum for a rapid exchange of comments and information concerning previously published papers and topics of current interest. Meeting reports provide current information on the latest results presented at important congresses.
The following fields are covered: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; and epidemiology.
- Official Journal of the German Cancer Society (Deutsche Krebsgesellschaft)
- Publishes significant and up-to-date articles within the fields of experimental and clinical oncology
- Presents original papers, reviews, rapid communications, letters and editorials
- 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Journal information
- Editor-in-Chief
-
- Klaus Höffken
- Publishing model
- Hybrid. Open Access options available
Journal metrics
- 3.332 (2018)
- Impact factor
- 3.067 (2018)
- Five year impact factor
- 13 days
- Submission to first decision
- 78 days
- Submission to acceptance
- 268,469 (2018)
- Downloads
Latest articles
-
-
“Hedgehog pathway”: a potential target of itraconazole in the treatment of cancer
Authors (first, second and last of 4)
-
Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis
Authors (first, second and last of 6)
-
-
Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study
Authors (first, second and last of 8)
Subscribe
- Subscription
- $199.00
- Note this is only the net price. Taxes will be calculated during checkout.
- Immediate online access
- Full Journal access includes all articles
- Downloadable in PDF
- Subscription expires 12/31/2020
Advertisement
About this journal
- Electronic ISSN
- 1432-1335
- Print ISSN
- 0171-5216
- Abstracted and indexed in
-
- AGRICOLA
- BIOSIS
- Biological Abstracts
- CAB Abstracts
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Elsevier Biobase
- Gale
- Gale Academic OneFile
- Gale InfoTrac
- Google Scholar
- INIS Atomindex
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Oncogenes and Growth Factors Abstracts
- ProQuest Pharma Collection
- ProQuest Public Health Database
- ProQuest Research Library
- ProQuest SciTech Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- Copyright information
-
© Springer-Verlag GmbH Germany, part of Springer Nature
